» Articles » PMID: 36703758

Curcumae Rhizoma: A Botanical Drug Against Infectious Diseases

Overview
Journal Front Pharmacol
Date 2023 Jan 27
PMID 36703758
Authors
Affiliations
Soon will be listed here.
Abstract

Curcumae Rhizoma is the dry rhizome coming from Curcuma longa L. which grow widely in tropical south and southwest Asia. It has been used to treat conditions such as dermatoses, infections, stress, and depression. Moreover, in China, Curcumae Rhizoma and its active constituents have been made into different pharmaceutical preparations. Growing evidence suggests that these preparations can exert antioxidant, anti-inflammatory, and anti-cancer effects, which may play crucial roles in the treatment of various diseases, including cancer, infectious-, autoimmune-, neurological-, and cardiovascular diseases, as well as diabetes. The anti-infective effect of Curcumae Rhizoma has become a popular field of research around the world, including for the treatment of COVID-19, influenza virus, hepatitis B virus, human immunodeficiency virus, and human papilloma virus, among others. In this paper, the basic characteristics of Curcumae Rhizoma and its active constituents are briefly introduced, and we also give an overview on their applications and mechanisms in infectious diseases.

Citing Articles

Clinical Trial Findings and Drug Development Challenges for Curcumin in Infectious Disease Prevention and Treatment.

El Oirdi M, Farhan M Life (Basel). 2024; 14(9).

PMID: 39337921 PMC: 11432846. DOI: 10.3390/life14091138.


Role of Curcuma longae Rhizoma in medical applications: research challenges and opportunities.

Zhang P, Liu H, Yu Y, Peng S, Zhu S Front Pharmacol. 2024; 15:1430284.

PMID: 39170702 PMC: 11336575. DOI: 10.3389/fphar.2024.1430284.


Research Progress on Sesquiterpenoids of and Their Pharmacological Effects.

Cui T, Li B, Liu F, Xiong L Biomolecules. 2024; 14(4).

PMID: 38672405 PMC: 11048675. DOI: 10.3390/biom14040387.

References
1.
Li C, Zhang L, Dezube B, Crumpacker C, Pardee A . Three inhibitors of type 1 human immunodeficiency virus long terminal repeat-directed gene expression and virus replication. Proc Natl Acad Sci U S A. 1993; 90(5):1839-42. PMC: 45975. DOI: 10.1073/pnas.90.5.1839. View

2.
Romoli J, Silva M, Pante G, Hoeltgebaum D, Castro J, da Rocha G . Anti-mycotoxigenic and antifungal activity of ginger, turmeric, thyme and rosemary essential oils in deoxynivalenol (DON) and zearalenone (ZEA) producing . Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2021; 39(2):362-372. DOI: 10.1080/19440049.2021.1996636. View

3.
Wang Z, Yin C, Gao Y, Liao Z, Li Y, Wang W . Novel functionalized selenium nanowires as antibiotic adjuvants in multiple ways to overcome drug resistance of multidrug-resistant bacteria. Biomater Adv. 2022; 137:212815. DOI: 10.1016/j.bioadv.2022.212815. View

4.
Yu W, Qin X, Zhang Y, Qiu P, Wang L, Zha W . Curcumin suppresses doxorubicin-induced cardiomyocyte pyroptosis via a PI3K/Akt/mTOR-dependent manner. Cardiovasc Diagn Ther. 2020; 10(4):752-769. PMC: 7487371. DOI: 10.21037/cdt-19-707. View

5.
Sandur S, Pandey M, Sung B, Ahn K, Murakami A, Sethi G . Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism. Carcinogenesis. 2007; 28(8):1765-73. DOI: 10.1093/carcin/bgm123. View